Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients
Abstract Objective: Patients receiving hematopoietic stem cell transplants (HSCT) are at increased risk for Clostridioides difficile infection (CDI). The purpose of this study was to assess the effectiveness of oral vancomycin prophylaxis (OVP) for CDI in HSCT patients. Design: Single-center, retros...
Saved in:
Main Authors: | Kelly M. Reitmeyer (Author), Brijesh Rana (Author), David Awad (Author), Esther Huang (Author), Jiyeon J. Park (Author), Arsheena Yassin (Author), John P. Mills (Author), Ahmed Abdul Azim (Author), Pinki J. Bhatt (Author), Navaneeth Narayanan (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
by: Zeitler Kristen, et al.
Published: (2023) -
Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology Patients
by: Anjali Majumdar, et al.
Published: (2023) -
Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
by: A. Krishna Rao, et al.
Published: (2022) -
Impact of <i>Clostridioides difficile</i> Therapy on Nosocomial Acquisition of Vancomycin-Resistant Enterococci
by: Carlos L. Correa-Martínez, et al.
Published: (2021) -
Genetic Mechanisms of Vancomycin Resistance in <i>Clostridioides difficile</i>: A Systematic Review
by: Taryn A. Eubank, et al.
Published: (2022)